An odyssey of islet transplantation for therapy of type 1 diabetes

Related Experiment Video

Updated: Jul 14, 2026

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

Garth L Warnock1, Yu Huan Theresa Liao, Xiaojie Wang

  • 1Department of Surgery, University of British Columbia Medical Center, 910 West 10th Avenue, Vancouver, British Columbia V5Z 4E3. gwarnock@interchange.ubc.ca

World Journal of Surgery
|June 15, 2007
PubMed

Insights

Canadian researchers have significantly advanced islet transplantation for type 1 diabetes. This review highlights key laboratory and clinical contributions shaping future therapies.

Area of Science:

  • Surgical Innovation
  • Transplantation Science
  • Endocrinology

Background:

  • Canadian surgical expertise in islet transplantation is well-established.
  • The field has a history of significant innovation and future potential.

Purpose of the Study:

  • To review seminal Canadian contributions to islet transplantation.
  • To highlight advancements from basic research to clinical applications for type 1 diabetes.

Main Methods:

  • Literature review of Canadian contributions.
  • Analysis of basic science research.
  • Evaluation of translational applications to patient care.

Main Results:

  • Documented significant Canadian advancements in islet isolation and transplantation techniques.
  • Identified key translational research bridging laboratory findings to clinical practice.
  • Showcased the impact of Canadian research on type 1 diabetes treatment.

Conclusions:

  • Canadian contributions are pivotal to the progress of islet transplantation.
  • Continued research and innovation promise improved therapies for type 1 diabetes.

More Related Videos

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation17:42

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.